MedTrace Logo

A-protein Levels in Adult and Pediatric Brain Tumor Patients

NCT00165542 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2016-11-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate the sensitivity and specificity of "A-PROTEIN" levels in patients with brain tumors. A-PROTEIN levels will be analyzed both pre and post treatment. Levels in blood and/or cerebrospinal fluid (CSF) will be analyzed and correlated with the underlying diagnosis and outcome.

Conditions

  • Malignant Childhood Central Nervous System Neoplasm

Interventions

OTHER

A PROTEIN level

Sponsors & Collaborators

Principal Investigators

  • Mark W Kieran, MD,PhD · Dana-Farber Cancer Institute

Eligibility

Max Age
77 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-06-30
Primary Completion
2004-02-29
Completion
2009-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00165542 on ClinicalTrials.gov